Lowest Price Guaranteed From USD 4,799
Published
March 2023
Pages
360
View Count
11089
Example Insights
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Report Description
The global cell therapy media, cell therapy kits, cell therapy reagents and other consumables market is estimated to be worth $1.2 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 12% during the forecast period. The therapeutic approach involving the injection of healthy cells in the human body to replace the diseased / non-functioning cells, in order to regulate certain functions, is referred to as cell therapy. In the past few years, this therapeutic approach has emerged as one of the key areas of interest in the healthcare sector, given its ability to treat diseases which were previously considered untreatable. Consequently, driven by the benefits offered by cellular therapies and recent approvals granted by regulatory authorities, the demand for cellular therapies has increased considerably; this has led to a rise in the requirement of cell therapy raw materials. Specifically, cell therapy consumables refer to materials that are used in cell therapy manufacturing. It is worth mentioning that the selection of cell therapy consumables, specifically the cell culture media and supplements, is a crucial step in cell therapy manufacturing as they directly impact the potency and safety of the final product. In this report, we have considered the four predominant types of consumables applicable to cell therapy, namely cell culture media, media kits providing culture media along with the necessary media supplements, reagents and extracellular matrices.
The Cell Therapy Media, Cell Therapy Kits, Cell Therapy Reagents and Cell Therapy Surface Market (2nd Edition): Distribution by Type of Product (Culture Media, Kits, Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End-User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa (MENA) and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and the likely future potential of the cell culture media (supplied alone or in kits as a combination with cell growth supplements), cell culture reagents and ECM market, over the next 12 years. It highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Key inclusions of the report are briefly discussed below.
Since the development of the first cell therapy, this therapeutic segment has garnered significant attention from researchers and medical practitioners. This can be attributed to the fact that cell therapies have been demonstrated to possess a vast potential in the treatment of rare disorders, which were previously considered incurable. The popularity of this therapeutic class of products can also be validated from the fact that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. It is also worth mentioning that over 35 cell and gene therapies have already been commercialized, across various geographical locations, till date. Notable examples of recently approved cell therapies include (in reverse chronological order) Breyanzi® (June 2022), Carvykti™ (February 2022) and Abecma® (March 2021).
Driven by the rise in popularity of cell therapies, there is a growth in demand for cell culture media, reagents and surfaces. It is worth mentioning that, amidst the increasing demand for such products, there is a rise in stringency from regulatory authorities to ensure that the quality of raw materials is good. Therefore, to meet the industry needs, cell therapy manufacturers are actively adopting serum free and xeno free products, which are known to reduce the risk of batch-to-batch variability.
Currently, the marketed cell-based therapies are exorbitantly priced. Even though, with the introduction of automation technologies in cell therapy bioprocessing, the cost and time required for development of such products has reduced significantly, there is still a considerable scope of improvement to make these therapies affordable.
In this context, it is worth mentioning that consumables, including media, reagents and matrices, currently constitute nearly 25% of the overall cost of cell therapy manufacturing. Optimization of raw materials, by streamlining the production processes, can help mitigate wastage and further reduce the manufacturing cost. Moreover, for commercial applications, it is crucial to obtain consistent outcomes during the manufacturing process. Cell culture media, with chemically defined formulation, provides enhanced consistency for production purposes.
The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Some of these players also claim to have developed GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells. Subsequently, cell therapy media market represents majority share (57%) of consumables offered, followed by the share captured by media and supplement kits (26%), extracellular matrices (14%) and cell culture reagents (3%). The ancillary materials offered by these companies are available in various volumes and can be utilized for numerous functions, such as cell proliferation, cell differentiation and cell isolation. Recent developments in this domain indicate that cell therapy consumable providers are actively expanding their capacity and product portfolio in order to accommodate the current and anticipated demand for cell therapies.
In recent years, there has been a considerable rise in regulatory stringency as well as awareness related to disadvantages of using animal-based medica formulations, in the cell therapy domain. Specifically, animal-based media pose an undesirable risk of transfecting infectious agents. This has resulted in a shift towards the higher adoption of chemically defined, animal-component free (serum-free and xeno-free) media, in the cell culture media market. It is worth mentioning that, currently, majority of the cell culture media are being used for the development of stem cell therapies, followed by those intended for T-cell therapies.
One of the key drivers of the investments in this market is the success of previously commercialized cell therapies. More than USD 35 billion has already invested in cell therapy domain by private investors. In the last few years, cell therapies have offered a relatively more reliable approach for the treatment of rare diseases. According to a study published in 2019, the prevalence rate of rare diseases is about 263 to 446 million individuals, at any point of time. This necessitates the need for more such life-saving therapies. It is worth highlighting that, by 2030, close to 60 cell and gene therapies are anticipated to receive regulatory approval, further expanding the opportunities associated within the market. These factors will, in turn, lead to a surge in the requirement for cell therapy consumables products, driving significant growth of the domain.
Driven by the indubitably rising need for cell therapies, the market for cell therapy media and other consumables is anticipated to grow at a CAGR of 12%, during the period 2023-2035. Specifically, in terms of scale of operation, the demand for consumable products for commercial operations are expected to expand rapidly with the anticipated approval of numerous cell therapies. Additionally, it is worth highlighting that more than 80% of the current market share is captured by players based in North America and Asia-Pacific.
Examples of players engaged in this domain (which have also been captured in this report) include BD Biosciences, Bio-Techne, CellGenix, Corning, Irvine Scientific (Acquired by FUJIFILM), Lonza, Miltenyi Biotech, Sartorius, STEMCELL Technologies and Thermo Fisher Scientific.
Several recent developments have taken place in the field of cell therapy media. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments as defined in the below table:
Key Report Attributes | Details | |
Forecast Period |
|
|
Type of Product |
|
|
Type of Cell Therapy |
|
|
Scale of Operation |
|
|
Type of End-User |
|
|
Key Geographical Regions |
|
|
Key Companies Profiled |
|
|
Customization Scope |
|
|
PowerPoint Presentation (Complimentary) |
|
|
Excel Data Packs (Complimentary) |
|
The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:
One of the key objectives of the report was to estimate the current opportunity and the future growth potential of the cell therapy consumables market over the coming years. We have provided an informed estimate on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on relevant parameters, such as type of product (kits, media, reagents and extracellular matrices), type of cell therapy (t-cell therapies, stem cell therapies, dendritic cell therapies and NK cell therapies), scale of operation (clinical and commercial), type of end-user (industry and non-industry) and key geographical regions (North America, Europe, Asia-Pacific, MENA and Latin America). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios of the industry’s evolution.
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kit Manufacturing Facilities
4.2.5. Analysis by Certifications / Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Kit Components
4.2.10. Analysis by Storage Temperature
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Application Area
4.2.13. Analysis by Application Area and Geography
4.3. List of Cell Therapy Media Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Manufacturing Facilities
4.3.5. Analysis by Certifications / Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Compatibility
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Storage Temperature
4.3.11. Analysis by Volume of Media
4.3.12. Analysis by Scale of Operation
4.3.13. Analysis by Application Area
4.3.14. Analysis by Application Area and Geography
4.4. List of Cell Therapy Reagent Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Manufacturing Facilities
4.4.5. Analysis by Certifications / Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Storage Temperature
4.4.10. Analysis by Volume of Reagent
4.4.11. Analysis by Scale of Operation
4.4.12. Analysis by Application Area
4.4.13. Analysis by Application Area and Geography
4.5. List of Cell Therapy Extracellular Matrix Providers
4.5.1. Analysis by Year of Establishment
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters
4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
4.5.5. Analysis by Certifications / Accreditations Received
4.5.6. Analysis by Type of End-User
4.5.7. Analysis by Type of Stem Cell Therapy
4.5.8. Analysis by Type of Function
4.5.9. Analysis by Type of ECM Coating
4.5.10. Analysis by Type of Formulation
4.5.11. Analysis by Shelf Life
4.5.12. Analysis by Storage Temperature
4.5.13. Analysis by Volume of Extracellular Matrix
4.5.14. Analysis by Scale of Operation
4.5.15. Analysis by Application Area
4.5.16. Analysis by Application Area and Geography
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumable Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.6.1. Cell Therapy Media Providers based in North America
5.6.2. Cell Therapy Media Providers based in Europe
5.6.3. Cell Therapy Media Providers based in Asia-Pacific
5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers
6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Miltenyi Biotec
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Thermo Fisher Scientific
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Bio-Techne
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook
7.8. Sartorius
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook
7.9. BD Biosciences
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook
7.10. Corning
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook
7.11. CellGenix
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook
8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Product and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Region
8.3.9.1. Intercontinental and Intracontinental Agreements
8.3.9.2. Local and International Agreements
8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
8.4.2. Analysis by Type of Agreement
8.4.3. Analysis by Key Value Drivers
8.4.4. Analysis by Year of Acquisition and Key Value Drivers
8.5. Cell Therapy Consumables: Recent Expansions
8.5.1. Analysis by Year of Expansion
8.5.2. Analysis by Type of Expansion
8.5.3. Analysis by Year and Type of Expansion
8.5.4. Analysis by Type of Product
8.5.5. Analysis by Type of Expansion and Type of Product
8.5.6. Analysis by Area of Expansion
8.5.7. Most Active Players: Analysis by Number of Expansions
8.5.8. Analysis by Region
8.5.8.1. Analysis by Location of Facility (Continent-wise)
8.5.8.2. Analysis by Location of Facility (Country-wise)
8.5.9. Analysis by Type of Expansion and Location of Facility
9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
9.4.4. Likely Partners for T-Cell Therapy Consumable Providers
10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework
10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
10.2.1.1. Methodology
10.2.1.2. Results and Interpretation
10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
10.2.2.1. Methodology
10.2.2.2. Results and Interpretation
10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function
11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035
12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035
12.4.2. Cell Therapy Consumables Market for Kits, 2023-2035
12.4.3. Cell Therapy Consumables Market for Media, 2023-2035
12.4.4. Cell Therapy Consumables Market for Reagents, 2023-2035
12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035
12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035
12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035
12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035
12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.6.1. Cell Therapy Consumables Market for Clinical Operations, 2023-2035
12.6.2. Cell Therapy Consumables Market for Commercial Operations, 2023-2035
12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.7.1. Cell Therapy Consumables Market for Industry Players, 2023-2035
12.7.2. Cell Therapy Consumables Market for Non-Industry Players, 2023-2035
12.8. Cell Therapy Consumables Market: Analysis by Geography
12.8.1. Cell Therapy Consumables Market in North America, 2023-2035
12.8.1.1. Cell Therapy Consumables Market in the US, 2023-2035
12.8.1.2. Cell Therapy Consumables Market in Canada, 2023-2035
12.8.1.3. Cell Therapy Consumables Market in Rest of North America, 2023-2035
12.8.2. Cell Therapy Consumables Market in Europe, 2023-2035
12.8.2.1. Cell Therapy Consumables Market in Spain, 2023-2035
12.8.2.2. Cell Therapy Consumables Market in France, 2023-2035
12.8.2.3. Cell Therapy Consumables Market in Germany, 2023-2035
12.8.2.4. Cell Therapy Consumables Market in Italy, 2023-2035
12.8.2.5. Cell Therapy Consumables Market in the Netherlands, 2023-2035
12.8.2.6. Cell Therapy Consumables Market in the UK, 2023-2035
12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, 2023-2035
12.8.3. Cell Therapy Consumables Market in Asia-Pacific, 2023-2035
12.8.3.1. Cell Therapy Consumables Market in China, 2023-2035
12.8.3.2. Cell Therapy Consumables Market in Korea, 2023-2035
12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035
12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035
12.8.5. Cell Therapy Consumables Market in Latin America, 2023-2035
13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing
14. CONCLUDING REMARKS
15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Akadeum Life Sciences
15.2.1. Interview Transcript: Michael Maloney, Vice President of Business Development - Cell Therapy
15.3. Cellular Engineering Technologies
15.3.1. Interview Transcript: Anant Kamath, Chief Operating Officer
15.4. HiMedia Laboratories
15.4.1. Interview Transcript: Vishal G. Warke, Director R&D, Cell Culture and Immunology and Gauri W. Page, Assistant R&D Manager, Animal Cell Culture
16. APPENDIX I: TABULATED DATA
17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Recent Developments and Initiatives
Figure 2.3 Executive Summary: Demand Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Types of Cell Therapy Consumables
Figure 4.1 Cell Therapy Consumables: Distribution by Type of Product
Figure 4.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Figure 4.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Figure 4.4 Cell Therapy Kit Providers: Distribution by Company Size
Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Figure 4.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Figure 4.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Figure 4.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Figure 4.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Figure 4.10 Cell Therapy Kits: Distribution by Type of Function
Figure 4.11 Cell Therapy Kits: Distribution by Kit Components
Figure 4.12 Cell Therapy Kits: Distribution by Storage Temperature
Figure 4.13 Cell Therapy Kits: Distribution by Scale of Operation
Figure 4.14 Cell Therapy Kits: Distribution by Application Area
Figure 4.15 Cell Therapy Kit Providers: Distribution by Application Area and Geography
Figure 4.16 Cell Therapy Media Providers: Distribution by Year of Establishment
Figure 4.17 Cell Therapy Media Providers: Distribution by Company Size
Figure 4.18 Cell Therapy Media Providers: Distribution by Location of Headquarters
Figure 4.19 Cell Therapy Media Providers: Distribution by Location of Media ManufacturingFacilities
Figure 4.20 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Figure 4.21 Cell Therapy Media Providers: Distribution by Type of End-User
Figure 4.22 Cell Therapy Media: Distribution by Type of Cell Therapy
Figure 4.23 Cell Therapy Media: Distribution by Media Compatibility
Figure 4.24 Cell Therapy Media: Distribution by Type of Function
Figure 4.25 Cell Therapy Media: Distribution by Storage Temperature
Figure 4.26 Cell Therapy Media: Distribution by Volume of Media
Figure 4.27 Cell Therapy Media: Distribution by Scale of Operation
Figure 4.28 Cell Therapy Media: Distribution by Application Area
Figure 4.29 Cell Therapy Media Providers: Distribution by Application Area and Geography
Figure 4.30 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Figure 4.31 Cell Therapy Reagent Providers: Distribution by Company Size
Figure 4.32 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Figure 4.33 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Figure 4.34 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Figure 4.35 Cell Therapy Reagent Providers: Distribution by Type of End-User
Figure 4.36 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Figure 4.37 Cell Therapy Reagents: Distribution by Type of Function
Figure 4.38 Cell Therapy Reagents: Distribution by Storage Temperature
Figure 4.39 Cell Therapy Reagents: Distribution by Volume of Reagent
Figure 4.40 Cell Therapy Reagents: Distribution by Scale of Operation
Figure 4.41 Cell Therapy Reagents: Distribution by Application Area
Figure 4.42 Cell Therapy Reagent Providers: Distribution by Application Area and Geography
Figure 4.43 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Figure 4.44 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Figure 4.45 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Figure 4.46 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Figure 4.47 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Figure 4.48 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Figure 4.49 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Figure 4.50 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Figure 4.51 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Figure 4.52 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Figure 4.53 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Figure 4.54 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Figure 4.55 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Figure 4.56 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Figure 4.57 Cell Therapy Extracellular Matrices: Distribution by Application Area
Figure 4.58 Cell Therapy Extracellular Matrix Providers: Distribution by Application Area and Geography
Figure 5.1 Company Competitiveness Analysis: Cell Therapy Kit Providers
Figure 5.2 Company Competitiveness Analysis: Cell Therapy Media Providers based in North America
Figure 5.3 Company Competitiveness Analysis: Cell Therapy Media Providers based in Europe
Figure 5.4 Company Competitiveness Analysis: Cell Therapy Media Providers based in Asia-Pacific
Figure 5.5 Company Competitiveness Analysis: Cell Therapy Reagent Providers
Figure 5.6 Company Competitiveness Analysis: Cell Therapy Extracellular Matrix Providers
Figure 6.1 Brand Positioning Matrix: STEMCELL Technologies
Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec
Figure 6.3 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 6.4 Brand Positioning Matrix: Takara Bio
Figure 6.5 Brand Positioning Matrix: GeminiBio
Figure 7.1 STEMCELL Technologies: Product Portfolio
Figure 7.2 Miltenyi Biotec: Product Portfolio
Figure 7.3 Thermo Fisher Scientific: Product Portfolio
Figure 7.4 Bio-Techne: Product Portfolio
Figure 7.5 Irvine Scientific: Product Portfolio
Figure 7.6 Lonza: Product Portfolio
Figure 7.7 Sartorius: Product Portfolio
Figure 7.8 BD Biosciences: Product Portfolio
Figure 7.9 Corning: Product Portfolio
Figure 7.10 CellGenix: Product Portfolio
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.10 Partnerships and Collaborations: Local and International Agreements
Figure 8.11 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Figure 8.12 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.15 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Figure 8.16 Recent Expansions: Distribution by Type of Expansion
Figure 8.17 Recent Expansions: Distribution by Year and Type of Expansion
Figure 8.18 Recent Expansions: Distribution by Type of Product
Figure 8.19 Recent Expansions: Distribution by Type of Expansion and Type of Consumable
Figure 8.20 Recent Expansions: Distribution by Area of Expansion (Sq. Ft.)
Figure 8.21 Most Active Players: Distribution by Number of Expansions
Figure 8.22 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Figure 8.23 Recent Expansions: Distribution by Location of Facility (Country-wise)
Figure 8.24 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Figure 10.1 Cell Therapy Media: Roots Analysis Pricing Strategy Matrix
Figure 10.2 Cell Therapy Media: Roots Analysis Pricing Strategy Graphical Interpretation
Figure 10.3 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Matrix
Figure 10.4 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Graphical Interpretation
Figure 11.1 Global Demand for Cell Therapy Consumables, 2023-2035 (Thousand Liters)
Figure 11.2 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Thousand Liters)
Figure 11.3 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Thousand Liters)
Figure 11.4 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Figure 11.5 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Figure 11.6 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Figure 11.7 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Thousand Liters)
Figure 11.8 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Thousand Liters)
Figure 12.1 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Figure 12.2 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Figure 12.3 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Figure 12.4 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Figure 12.5 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Figure 12.6 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Figure 12.7 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Figure 12.8 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Figure 12.9 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Figure 12.10 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Figure 12.11 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Figure 12.12 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Figure 12.13 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Figure 12.14 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Figure 12.15 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Figure 12.16 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Figure 12.17 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Figure 12.18 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Figure 12.19 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Figure 12.20 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Figure 12.21 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Figure 12.22 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Figure 12.23 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Figure 12.24 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Figure 12.25 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Figure 12.26 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Figure 12.27 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Figure 12.28 Cell Therapy Consumables Market in the Netherlands, 2023-2035 (USD Million)
Figure 12.29 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Figure 12.30 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Figure 12.31 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 12.32 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Figure 12.33 Cell Therapy Consumables Market in Korea, 2023-2035 (USD Million)
Figure 12.34 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Figure 12.35 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.36 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Landscape
Figure 14.2 Concluding Remarks: Recent Developments
Figure 14.3 Concluding Remarks: Demand Analysis
Figure 14.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 3.1 Cell Therapies: Applications
Table 3.2 Differences between Cell Therapies and Other Biopharmaceuticals
Table 3.3 Key Cell Therapy Manufacturing Steps
Table 3.4 Types of Media Used in Cell Therapy Manufacturing
Table 4.1 List of Cell Therapy Kit Providers
Table 4.2 Cell Therapy Kits: Information on Type of Cell Therapy and Type of Function
Table 4.3 Cell Therapy Kits: Information on Kit Components and Storage Temperature
Table 4.4 Cell Therapy Kits: Information on Scale of Operation and Application Area
Table 4.5 List of Cell Therapy Media Providers
Table 4.6 Cell Therapy Media: Information on Type of Cell Therapy, Media Compatibility and Type of Function
Table 4.7 Cell Therapy Media: Information on Storage Temperature and Volume of Media
Table 4.8 Cell Therapy Media: Information on Scale of Operation and Application Area
Table 4.9 List of Cell Therapy Reagent Providers
Table 4.10 Cell Therapy Reagents: Information on Type of Cell Therapy and Type of Function
Table 4.11 Cell Therapy Reagents: Information on Storage Temperature and Volume of Reagent
Table 4.12 Cell Therapy Reagents: Information on Scale of Operation and Application Area
Table 4.13 List of Cell Therapy Extracellular Matrix Providers
Table 4.14 Cell Therapy Extracellular Matrices: Information on Type of Stem Cell Therapy and Type of Function
Table 4.15 Cell Therapy Extracellular Matrices: Information on Type of ECM Coating and Type of Formulation
Table 4.16 Cell Therapy Extracellular Matrices: Information on Shelf Life, Storage Temperature and Volume of Extracellular Matrix
Table 4.17 Cell Therapy Extracellular Matrices: Information on Scale of Operation and Application Area
Table 7.1 STEMCELL Technologies: Company Overview
Table 7.2 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.3 Miltenyi Biotec: Company Overview
Table 7.4 Miltenyi Biotec: Recent Developments and Future Outlook
Table 7.5 Thermo Fisher Scientific: Company Overview
Table 7.6 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.7 Bio-Techne: Company Overview
Table 7.8 Bio-Techne: Recent Developments and Future Outlook
Table 7.9 Irvine Scientific: Company Overview
Table 7.10 Irvine Scientific: Recent Developments and Future Outlook
Table 7.11 Lonza: Company Overview
Table 7.12 Sartorius: Company Overview
Table 7.13 Sartorius: Recent Developments and Future Outlook
Table 7.14 BD Biosciences: Company Overview
Table 7.15 BD Biosciences: Recent Developments and Future Outlook
Table 7.16 Corning: Company Overview
Table 7.17 CellGenix: Company Overview
Table 7.18 CellGenix: Recent Developments and Future Outlook
Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, 2015-2022
Table 8.2 Cell Therapy Consumables: Information on Location of Headquarters, 2015-2022
Table 8.3 Mergers and Acquisitions: List of Mergers and Acquisitions, 2016-2022
Table 8.4 Mergers and Acquisitions: Information on Key Value Drivers, 2016-2022
Table 8.5 Cell Therapy Consumables: List of Recent Expansions, 2017-2022
Table 9.1 Key Potential Strategic Partners for Cell Therapy Consumable Providers
Table 9.2 Likely Partners for Dendritic Cell Therapy Consumable Providers
Table 9.3 Likely Partners for NK Cell Therapy Consumable Providers
Table 9.4 Likely Partners for Stem Cell Therapy Consumable Providers
Table 9.5 Likely Partners for T-Cell Therapy Consumable Providers
Table 10.1 Media Price Evaluation Matrix: Based on Volume of Media
Table 10.2 Media Price Evaluation Matrix: Based on Media Compatibility
Table 10.3 Media Price Evaluation Matrix: Based on Type of Product Manufacturing Practices
Table 10.4 Media Price Evaluation Matrix: Based on Application Area
Table 10.5 Media Price Evaluation Matrix: Based on Storage Temperature
Table 10.6 Media Price Evaluation Matrix: Based on Type of Cell Therapy
Table 10.7 Media Price Evaluation Matrix: Based on Type of Function
Table 10.8 ECM Price Evaluation Matrix: Based on Type of ECM Coating
Table 10.9 ECM Price Evaluation Matrix: Based on Type of Formulation
Table 10.10 ECM Price Evaluation Matrix: Based on Volume of Extracellular Matrix
Table 10.11 ECM Price Evaluation Matrix: Based on Storage Temperature
Table 10.12 ECM Price Evaluation Matrix: Based on Shelf Life
Table 10.13 ECM Price Evaluation Matrix: Based on Type of Stem Cell Therapy
Table 10.14 ECM Price Evaluation Matrix: Based on Type of Function
Table 15.1 Akadeum Life Sciences: Key Highlights
Table 15.2 Cellular Engineering Technologies: Key Highlights
Table 15.3 HiMedia Laboratories: Key Highlights
Table 16.1 Cell Therapy Consumables: Distribution by Type of Product
Table 16.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Table 16.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Table 16.4 Cell Therapy Kit Providers: Distribution by Company Size
Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Table 16.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Table 16.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Table 16.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Table 16.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Table 16.10 Cell Therapy Kits: Distribution by Type of Function
Table 16.11 Cell Therapy Kits: Distribution by Kit Components
Table 16.12 Cell Therapy Kits: Distribution by Storage Temperature
Table 16.13 Cell Therapy Kits: Distribution by Scale of Operation
Table 16.14 Cell Therapy Kits: Distribution by Application Area
Table 16.15 Cell Therapy Media Providers: Distribution by Year of Establishment
Table 16.16 Cell Therapy Media Providers: Distribution by Company Size
Table 16.17 Cell Therapy Media Providers: Distribution by Location of Headquarters
Table 16.18 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
Table 16.19 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Table 16.20 Cell Therapy Media Providers: Distribution by Type of End-User
Table 16.21 Cell Therapy Media: Distribution by Type of Cell Therapy
Table 16.22 Cell Therapy Media: Distribution by Media Compatibility
Table 16.23 Cell Therapy Media: Distribution by Type of Function
Table 16.24 Cell Therapy Media: Distribution by Storage Temperature
Table 16.25 Cell Therapy Media: Distribution by Volume of Media
Table 16.26 Cell Therapy Media: Distribution by Scale of Operation
Table 16.27 Cell Therapy Media: Distribution by Application Area
Table 16.28 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Table 16.29 Cell Therapy Reagent Providers: Distribution by Company Size
Table 16.30 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Table 16.31 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Table 16.32 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Table 16.33 Cell Therapy Reagent Providers: Distribution by Type of End-User
Table 16.34 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Table 16.35 Cell Therapy Reagents: Distribution by Type of Function
Table 16.36 Cell Therapy Reagents: Distribution by Storage Temperature
Table 16.37 Cell Therapy Reagents: Distribution by Volume of Reagent
Table 16.38 Cell Therapy Reagents: Distribution by Scale of Operation
Table 16.39 Cell Therapy Reagents: Distribution by Application Area
Table 16.40 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Table 16.41 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Table 16.42 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Table 16.43 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Table 16.44 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Table 16.45 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Table 16.46 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Table 16.47 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Table 16.48 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Table 16.49 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Table 16.50 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Table 16.51 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Table 16.52 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Table 16.53 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Table 16.54 Cell Therapy Extracellular Matrices: Distribution by Application Area
Table 16.55 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Table 16.56 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.57 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership, 2015-2022
Table 16.58 Partnerships and Collaborations: Distribution by Type of Product
Table 16.59 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Table 16.60 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Table 16.61 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Table 16.62 Most Active Players: Distribution by Number of Partnerships
Table 16.63 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.64 Partnerships and Collaborations: Local and International Agreements
Table 16.65 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Table 16.66 Mergers and Acquisitions: Distribution by Type of Agreement
Table 16.67 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 16.68 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers, 2016-2022
Table 16.69 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Table 16.70 Recent Expansions: Distribution by Type of Expansion
Table 16.71 Recent Expansions: Distribution by Year and Type of Expansion, 2017-2022
Table 16.72 Recent Expansions: Distribution by Type of Product
Table 16.73 Recent Expansions: Distribution by Type of Expansion and Type of Product
Table 16.74 Recent Expansions: Distribution by Area of Expansion
Table 16.75 Most Active Players: Distribution by Number of Expansions
Table 16.76 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Table 16.77 Recent Expansions: Distribution by Location of Facility (Country-wise)
Table 16.78 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Table 16.79 Global Demand for Cell Therapy Consumables, 2023-2035 (Thousand Liters)
Table 16.80 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Thousand Liters)
Table 16.81 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Thousand Liters)
Table 16.82 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Table 16.83 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Table 16.84 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Table 16.85 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Thousand Liters)
Table 16.86 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Thousand Liters)
Table 16.87 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Table 16.88 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Table 16.89 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Table 16.90 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Table 16.91 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Table 16.92 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Table 16.93 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Table 16.94 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Table 16.95 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Table 16.96 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Table 16.97 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Table 16.98 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Table 16.99 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Table 16.100 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Table 16.101 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Table 16.102 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Table 16.103 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Table 16.104 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Table 16.105 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Table 16.106 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Table 16.107 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Table 16.108 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Table 16.109 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Table 16.110 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Table 16.111 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Table 16.112 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Table 16.113 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Table 16.114 Cell Therapy Consumables Market in the Netherlands, 2023-2035 (USD Million)
Table 16.115 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Table 16.116 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Table 16.117 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Table 16.118 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Table 16.119 Cell Therapy Consumables Market in Korea, 2023-2035 (USD Million)
Table 16.120 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Table 16.121 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 16.122 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)
The following companies and organizations have been mentioned in the report:
Source 1: https://www.thermofisher.com/blog/behindthebench/raw-material-considerations-cell-therapy/
Source 2: https://www.cellandgene.com/doc/cell-gene-therapies-investment-outlook-in-beyond-0001